Science Explorer Back to mapMap
Discussion
Researcher · Novo Nordisk (Denmark) · Denmark

Nicolai R. Wagtmann

Nicolai R. Wagtmann publishes mostly in Immunology, Oncology and Radiology, Nuclear Medicine and Imaging, on topics such as Immune Cell Function and Interaction, T-cell and B-cell Immunology and CAR-T cell therapy research.

OpenAlex
World rank
#271,601
of 7,710,434 ranked researchers
Rank in Denmark
#1,889
of 43,819
Works
58
Citations
6.4k
Citations per work
109.8
h-index
30
i10-index 35Top 15% in Immunology
Nicolai R. Wagtmann

What does Nicolai R. Wagtmann research?

Nicolai R. Wagtmann's work is mostly in Immunology and Microbiology (57%), Medicine (24%), Neuroscience (4%).

Life Sciences: 37 works · 63.4% of their workImmunology and Microbiology: 33 works · 57.2% of their workImmunology: 33 works · 57.2% of their workNeuroscience: 2 works · 4.1% of their workCellular and Molecular Neuroscience: 2 works · 4.1% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 2.1% of their workMolecular Biology: 1 works · 2.1% of their workHealth Sciences: 14 works · 24.1% of their workMedicine: 14 works · 24.1% of their workOncology: 9 works · 15.9% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 4.8% of their workHematology: 2 works · 3.4% of their workEverything else: 7 works · 12.5% of their workTHEIR WORKNicolai R.Wagtmann58works
Life Sciences63%Health Sciences24%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology3357.2%
    2. Neuroscience24.1%
    3. Biochemistry, Genetics and Molecular Biology12.1%
    1. Medicine1424.1%
  3. Everything else712.5%
  1. 1Immunology57% of their works
  2. 2Oncology16% of their works
  3. 3Radiology, Nuclear Medicine and Imaging5% of their works
  4. 4Cellular and Molecular Neuroscience4% of their works
  5. 5Hematology3% of their works
  6. 6Molecular Biology2% of their works

Research topics

Which keywords describe Nicolai R. Wagtmann's research?

The keywords of their largest research topics: Natural Killer Cells, NK Cell Recognition, Foxp3, TGF-ß, Cancer Immunotherapy, Tumor Microenvironment, CAR T Cells and Chimeric Antigen Receptor.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. NK Cell Recognition371 topic
  2. Natural Killer Cells371 topic
  3. Foxp3231 topic
  4. TGF-ß231 topic
  5. Cancer Immunotherapy172 topics
  6. Tumor Microenvironment142 topics
  7. CAR T Cells91 topic
  8. Chimeric Antigen Receptor91 topic
  9. Dendritic Cells81 topic
  10. Immune Checkpoint Blockade81 topic
  11. Immunity81 topic
  12. PD-1 and PD-L181 topic
  13. Fc Receptors71 topic
  14. Therapeutic Antibodies71 topic
  15. Fibroblast Activation Protein61 topic
  16. Immunosuppression61 topic
  17. Neuropeptides61 topic
  18. Receptors61 topic

Where does Nicolai R. Wagtmann work?

Nicolai R. Wagtmann's main affiliation in the publication record is Novo Nordisk (Denmark), Denmark.

How many publications and citations does Nicolai R. Wagtmann have?

OpenAlex counts 58 works and 6,367 citations for Nicolai R. Wagtmann, an h-index of 30, ranking #271,601 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Nicolai R. Wagtmann. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.